Metsera Gets Higher Offers From Pfizer, Novo in Takeover Saga

Obesity drugmaker Metsera Inc. has gotten higher offers from both Novo Nordisk A/S and Pfizer Inc. in an ongoing battle for the startup.

By Madison Muller · Bloomberg Markets

Obesity drugmaker Metsera Inc. has gotten higher offers from both Novo Nordisk A/S and Pfizer Inc. in an ongoing battle for the startup.